SCHEMBL2944522

SCHEMBL2944522

COC(=O)C1CCC(NC(=O)CCO)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 4/20 0.43
NPSR1 Q6W5P4 1/20 0.42
SMYD3 Q9H7B4 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 3/20 0.39
MAPT P10636 2/20 0.38
SELL P14151 1/20 0.38
SELP P16109 1/20 0.38
SELE P16581 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TP53 P04637 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2944520 1.00 POLB (0.43) POLBSMN1; SMN2ALDH1A1NPSR1SMYD3
SCHEMBL2951974 0.86 POLB (0.45) POLBSMN1; SMN2ALDH1A1NPSR1GAA
SCHEMBL2951976 0.86 POLB (0.45) POLBSMN1; SMN2ALDH1A1NPSR1GAA
SCHEMBL26106226 0.84 POLB (0.46) POLBSMN1; SMN2ALDH1A1NPSR1SMYD3
SCHEMBL26106230 0.84 POLB (0.46) POLBSMN1; SMN2ALDH1A1NPSR1SMYD3
SCHEMBL6003417 0.83
SCHEMBL2941951 0.82 SMN1; SMN2 (0.47) POLBSMN1; SMN2ALDH1A1SMYD3HPGD
SCHEMBL2941952 0.82 SMN1; SMN2 (0.47) POLBSMN1; SMN2ALDH1A1SMYD3HPGD
SCHEMBL2947935 0.81 NPSR1 (0.45) POLBSMN1; SMN2ALDH1A1NPSR1GAA
SCHEMBL2947936 0.81 NPSR1 (0.45) POLBSMN1; SMN2ALDH1A1NPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737161-B2 Condensed furan compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-06-15 US disclosed
US-20090156803-A1 Condensed furan compounds KAWAGUCHI TAKAYUKI 2009-06-18 US disclosed
US-7514449-B2 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-04-07 US disclosed
US-20060094724-A1 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-05-04 US disclosed
EP-1582521-A1 FUSED FURAN COMPOUND TANABE SEIYAKU CO., LTD. (JP) 2005-10-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156803-A1 Condensed furan compounds F2, F12, F11 POLB 2463/4885SMN1; SMN2 4447/4885ALDH1A1 1627/4885
US-20060094724-A1 Fused furan compound F2, F12, F11 POLB 3282/4885SMN1; SMN2 4490/4885ALDH1A1 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.